Vaccine—screening method
US9833506B2 · kind B2 · utility
2Cited by
0References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 21, 2012 |
| Grant date | Dec 5, 2017 |
| Priority date | — |
| Expiry date | Dec 21, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides screening methods which may be regarded as in vitro or ex vivo methods of interrogating the immune system to understand what viral antigens are “seen” and responded to by T cells of the immune systems during viral infection. The screening methods further link in vitro or ex vivo responses to progression of infection in subjects.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.